All eyes on a hurdle race for a SARS-CoV-2 vaccine
Abstract
Leading COVID-19 vaccine candidates have progressed through laboratory tests at record speed. Two early clinical trials suggest that immunization delivers a favourable immune response and safety profile, but questions remain.
- Publication:
-
Nature
- Pub Date:
- October 2020
- DOI:
- 10.1038/d41586-020-02926-w
- Bibcode:
- 2020Natur.586..501G